Incyte's Blood Cancer Drug Program 'Looks Very Viable' Amid Development Challenges, RBC Says
Incyte's Blood Cancer Drug Program 'Looks Very Viable' Amid Development Challenges, RBC Says
5 months ago
marketscreener.com
Incyte Gets FDA Fast Track For Rare Blood Cancer Drug
Incyte Gets FDA Fast Track For Rare Blood Cancer Drug
5 months ago
investors.com
Every caregiver has a unique story. Whether it's a shoulder to lean on or driving a loved one to the doctor, each act is invaluable. Share what being a caregiver means to you below. | Incyte
0:05
Every caregiver has a unique story. Whether it's a shoulder to lean on or driving a loved one to the doctor, each act is invaluable. Share what being a caregiver means to you below. | Incyte
287.8K views6 months ago
FacebookIncyte
Meet Mary, an elementary school teacher and mother, who voiced concerns about symptoms like itching and blood in her stool for nearly a decade only to have them dismissed as hemorrhoids. By the time she was diagnosed, her anal cancer had spread to Stage 3. Mary hopes her story will inspire others to trust their instincts, have candid conversations about anal cancer risks and symptoms with their doctors, and advocate for their health – because treatment is available. | Incyte
0:31
Meet Mary, an elementary school teacher and mother, who voiced concerns about symptoms like itching and blood in her stool for nearly a decade only to have them dismissed as hemorrhoids. By the time she was diagnosed, her anal cancer had spread to Stage 3. Mary hopes her story will inspire others to trust their instincts, have candid conversations about anal cancer risks and symptoms with their doctors, and advocate for their health – because treatment is available. | Incyte
916K views6 months ago
FacebookIncyte
Let's Talk Anal Cancer. On Rare Cancer Day, we’re sharing how three anal cancer thrivers – Daniel, Mary and Susie – are posing a bold challenge: get comfortable saying the words "anal cancer." A rare cancer typically caused by a common skin-to-skin virus, they're calling anal cancer what it is and showing us why two little words shouldn't get in the way of important conversations with your doctor. Normalizing these conversations will help break down the barriers that can delay diagnosis and caus
1:21
Let's Talk Anal Cancer. On Rare Cancer Day, we’re sharing how three anal cancer thrivers – Daniel, Mary and Susie – are posing a bold challenge: get comfortable saying the words "anal cancer." A rare cancer typically caused by a common skin-to-skin virus, they're calling anal cancer what it is and showing us why two little words shouldn't get in the way of important conversations with your doctor. Normalizing these conversations will help break down the barriers that can delay diagnosis and caus
1.8K views7 months ago
FacebookIncyte
Incyte and Merck to collaborate on cancer drugs
Incyte and Merck to collaborate on cancer drugs
Apr 3, 2017
delawareonline.com
Incyte seeks billions after worker allegedly walks off with cancer drug secrets
Incyte seeks billions after worker allegedly walks off with cancer drug secrets
Oct 15, 2017
delawareonline.com
QIAGEN And Incyte Partner To Create New Test For Rare Blood Cancers
Feb 26, 2010
finanznachrichten.de
1:46
The role of CALR mutations in the initiation and progression of MPNs
2.5K viewsNov 15, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
Why Incyte Isn't Flying On Its First-Quarter Beat
2 weeks ago
investors.com
1:24
Incyte stock dives after drug trial disappoints investors
14.1K viewsMar 17, 2025
YahooYahoo Finance Video
4:20
Incyte CEO on the future of cancer treatment
Jun 5, 2017
CNBC
Incyte Corporation Announces Decision to Stop Phase 2 Sub-Study of Ruxolitinib Plus Regorafenib in Patients with Metastatic Colorectal Cancer and High CRP
Jan 27, 2016
marketscreener.com
Incyte CEO: We're building for the long term
Dec 5, 2016
CNBCScott Wapner
1:51
Incyte CEO: Science will drive success
Jun 2, 2014
CNBC
Incyte moves forward on expansion, announces cancer fund
Oct 6, 2017
delawareonline.com
Incyte | LinkedIn
Apr 4, 2025
linkedin.com
Incyte to pay $12.6 million to settle claims it provided kickbacks through charity
May 5, 2021
delawareonline.com
Incyte gets go-ahead on expansion plan at Augustine Cut-Off headquarters
Sep 27, 2019
delawareonline.com
0:58
Introducing the Incucyte® Live-Cell Analysis System: Antibody Internalization
963 viewsMay 10, 2023
YouTubeSartorius
Pharmaceutical giant Incyte will move into two of Wilmington's most iconic buildings
May 21, 2024
delawareonline.com
12:42
ESSENTIAL THROMBOCYTHEMIA Explained: Etiology. Molecular pathogenesis CALR JAK2 mutation
2K viewsAug 5, 2022
YouTubeFoxterrier
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
6 months ago
businesswire.com
12:55
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo...
25 views6 months ago
YouTubeBusinessWire
14:49
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo...
278 views6 months ago
YouTubeBusinessWire
Learn More About Clinical Trials | IncyteClinicalTrials.com
Mar 8, 2021
incyteclinicaltrials.com
3:05
Why is CALR an ideal immunotherapeutic target for MPNs?
1.5K viewsNov 4, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:53
Advancing ET & Myelofibrosis Care: mutCALR Antibody Therapy | John Mascarenhas, MD | #EHA2025
445 views10 months ago
YouTubeHealthTree University for Blood Cancers
0:26
Incyte Corporation: Innovating Cancer Treatments with Jakafi & Iclusig
11 views10 months ago
YouTubeStock Market Companies
0:59
#Sponsored by Incyte | Imagine being able to share a powerful image instead of relying on medical terms to describe symptoms. With the MPN VisualAIzer, patients with chronic blood cancers known as myeloproliferative neoplasms (MPNs) can do just that—which is important, not only to help with quality-of-life control but also for help managing the disease itself in partnership with care teams. Visit https://bit.ly/4olxCXL to use MPN VisualAIzer and learn more about the importance of tracking MPN sy
146.9K views7 months ago
FacebookSanjay Juneja, M.D.
See more